Onyx Bridge Wealth Group LLC Humanigen, Inc Transaction History

Onyx Bridge Wealth Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$0.12 - $0.23 $372 - $713	3,100 Added 12.43%	28,037 $3,000
Q4 2022 Jan 11, 2023	BUY	$0.09 - $0.2 $399 - $887	4,437 Added 21.64%	24,937 $0
Q3 2022 Oct 13, 2022	BUY	$0.15 - $3.02 $1,575 - $31,710	10,500 Added 105.0%	20,500 $3,000
Q2 2022 Jul 25, 2022	BUY	$1.76 - $3.33 $17,600 - $33,300	10,000 New	10,000 $4,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Onyx Bridge Wealth Group LLC, based on Form 13F filings with the SEC.

Stay updated on Onyx Bridge Wealth Group LLC with notifications on news.